JCAD: A Protein Involved in Cell-Cell Adhesion and Disease (G57608)

Target Name: JCAD

NCBI ID: G57608

JCAD

JCAD: A Protein Involved in Cell-Cell Adhesion and Disease

JCAD, or Junctional Cadherin 5-Associated Protein, is a protein that is expressed in various tissues throughout the body, including the skin, heart, and brain. It is a member of the cadherin family of transmembrane proteins, which are known for their role in cell-cell adhesion.

JCAD is characterized by its localization to the intercellular junctions, which are the sites where cells stick together to form tissues and organs. It helps to maintain the integrity of these junctions and is involved in the formation of tissues and organs during development and throughout life.

JCAD is also involved in the regulation of cell proliferation and has been shown to play a role in the development and progression of various diseases, including cancer. It has been shown to promote the growth and survival of cancer cells, and to inhibit the growth and survival of healthy cells.

In addition to its role in cancer, JCAD is also a potential drug target for a variety of other diseases. For example, JCAD has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. It has also been shown to be involved in the development of cardiovascular disease, including heart failure and hypertension.

JCAD is also a potential biomarker for a variety of diseases. For example, it has been shown to be a potential biomarker for cancer, both in terms of its expression levels and its ability to be targeted by cancer therapies. It has also been shown to be a potential biomarker for neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.

In conclusion, JCAD is a protein that is involved in a variety of processes throughout the body, including the regulation of cell proliferation and the formation of tissues and organs. It is also involved in the development and progression of various diseases, including cancer and neurodegenerative diseases. As a result, JCAD is a potential drug target and a potential biomarker for a variety of diseases. Further research is needed to fully understand the role of JCAD in these processes and to develop effective therapies for its targeting.

Protein Name: Junctional Cadherin 5 Associated

The "JCAD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about JCAD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets